---
title: "What investors don’t understand about Abbott Laboratories"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292900985.md"
description: "Abbott Laboratories is underpriced as investors view it merely as a slow-growth dividend stock, ignoring its strategic pivot. Key growth drivers include the FreeStyle Libre CGM franchise with significant untapped market potential and the $21B acquisition of Exact Sciences to launch a Cancer Diagnostics unit. Despite recent stock declines, Abbott maintains strong financial performance with consistent earnings beats and dividend increases, suggesting a disconnect between market perception and fundamental value."
datetime: "2026-07-16T11:55:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292900985.md)
  - [en](https://longbridge.com/en/news/292900985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292900985.md)
generator: "portal-rs"
---

# What investors don’t understand about Abbott Laboratories

Quick ReadAbbott trades at 17x forward earnings with shares 29% below the analyst consensus buy target, yet the company has posted four consecutive EPS beats.Despite DexCom competition, CEO Robert Ford sees the global CGM market growing from 12 million to 80 million users, anchored by FreeStyle Libre.Abbott's $21 billion Exact Sciences acquisition ...

### Related Stocks

- [EXAS.US](https://longbridge.com/en/quote/EXAS.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)

## Related News & Research

- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)
- [VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase](https://longbridge.com/en/news/296932909.md)
- [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md)
- [Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?](https://longbridge.com/en/news/296709148.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**